The Roles of Mesenchymal Stromal or Stem Cells in Cancer Therapy
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Gene and Cell Therapy".
Deadline for manuscript submissions: closed (30 November 2023) | Viewed by 539
Special Issue Editors
Interests: regenerative medicine; tissue engineering; tumor microenvironment; mesenchymal stromal/stem cells; tumorigenesis
Interests: mesenchymal stromal/stem cells; cellular therapy; cancer treatment; adipogenesis; obesity
Special Issue Information
Dear Colleagues,
The promising therapeutic value of mesenchymal stromal/stem cells (MSCs) and their secretome in many diseases, including cancer, has inspired many studies investigating their properties and behaviour. MSCs, which can be sourced from many tissues, are multipotent cells. They are recruited to tumour sites, in which they display pleiotropic behaviour, including modulation of immune responses and inflammation. MSCs also participate in tissue repair and regeneration. Thus, they are considered key in tissue regeneration and as potential delivery vehicles for anti-cancer therapy. Additionally, MSCs at tumour sites initiate immune responses, which demonstrate both pro- and anti-tumorigenic effects. As such, a deeper understanding of their role in tissue regeneration, tumorigenesis and cancer treatment is required.
This Special Issue will present recent advances in our knowledge on MSC and its secretome in tissue regeneration, tumorigenesis and cancer therapy. Original research articles and reviews are welcome.
Dr. Kevin Dzobo
Dr. Melvin Anyasi Ambele
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- mesenchymal stromal/stem cells
- secretome
- tumour microenvironment
- tissue regeneration
- cellular therapy
- cancer therapy
- cancer
- immune modulation
- inflammation
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
